Mark Purcell
Stock Analyst at Morgan Stanley
(0)
# 4200
Out of 5,328 analysts
5
Total ratings
50.00%
Success rate
-10.13%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NVS Novartis | Initiates Coverage On: Equal-Weight | 114 | 111.48 | 2.26% | 1 | Jan 23, 2024 | |
SNY Sanofi | Initiates Coverage On: Equal-Weight | 55 | 54.27 | 1.35% | 1 | Jan 23, 2024 | |
GSK GSK | Initiates Coverage On: Equal-Weight | 44 | 38.88 | 13.17% | 1 | Jan 23, 2024 | |
AZN AstraZeneca | Initiates Coverage On: Overweight | 85 | 70.61 | 20.38% | 1 | Jan 23, 2024 | |
NVO Novo Nordisk | Initiates Coverage On: Overweight | 120 | 65.92 | 82.04% | 1 | Jan 23, 2024 |